CPD/ADSOL Red Cell Preservation Solution System (PL 2209) (Fenwal, Inc.)
Welcome to the PulseAid listing for the CPD/ADSOL Red Cell Preservation Solution System (PL 2209) drug offered from Fenwal, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fenwal, Inc. |
NON-PROPRIETARY NAME: | Anticoagulant Citrate Phosphate Dextrose (CPD) Solution and ADSOL Preservation Solution |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-01-31 |
END MARKETING DATE: | 0000-00-00 |
CPD/ADSOL Red Cell Preservation Solution System (PL 2209) HUMAN PRESCRIPTION DRUG Details:
Item Description | CPD/ADSOL Red Cell Preservation Solution System (PL 2209) from Fenwal, Inc. |
LABELER NAME: | Fenwal, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2008-01-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0942-6478_ff4ecfbc-eec7-4940-ba47-214d6248e5fc |
PRODUCT NDC: | 0942-6478 |
APPLICATION NUMBER: | BN900223 |